BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• FDA

  Quidel Corporation Receives CE Mark for Its Molecular Diagnostic Test for Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV)

  March 13, 2012

   · 

  5 min read
• BioMidwest

  Perrigo Company to Present at the Barclays Capital Global Healthcare Conference

  March 13, 2012

   · 

  2 min read
• Drug Development

  Cell>Point Announces Agreement with FDA on Special Protocol Assessment for Phase 3 Trial of Technetium-99m-EC-G for Imaging Lung Cancer

  March 13, 2012

   · 

  1 min read
• Drug Development

  Dynavax Technologies Corporation Release: Phase 3 Data on HEPLISAV(TM) in Adults Aged 40-70 Published in VACCINE

  March 13, 2012

   · 

  3 min read
• D. Medical Industries Ltd. Receives NASDAQ Notification of Non-Compliance With Minimum Bid Price Rule

  March 13, 2012

   · 

  1 min read
• Business

  Orgenesis Announces Definitive Agreement to Acquire Autologous Insulin Producing Cells (AIPC) Regeneration Technology

  March 13, 2012

   · 

  1 min read
• Business

  Boehringer Ingelheim Corporation Plans Shanghai Animal Vaccine R&D Center

  March 13, 2012

   · 

  1 min read
• Business

  NicOx SA Shares Gain on Glaucoma Drug Study Results; Earns $10 Million Milestone Under Bausch & Lomb Accord

  March 13, 2012

   · 

  6 min read
• Deals

  Covidien plc Rumored to Buy superDimension, Inc. for $300 Million

  March 13, 2012

   · 

  1 min read
• BioMidwest

  Viewport Medical Systems Closes $45 Million Round of Series C Financing

  March 13, 2012

   · 

  1 min read